ScholarIQanswers from OpenAlex & ORCID
Paschalis Karakasis
ResearcherPublications, citations & collaboration network
Paschalis Karakasis is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Paschalis Karakasis have?
ScholarIQindexed works
Paschalis Karakasis has 175 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Paschalis Karakasis have?
ScholarIQcitation count
Paschalis Karakasis has 7,438 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Paschalis Karakasis?
ScholarIQh-index
Paschalis Karakasis has an h-index of 27 in OpenAlex.
What is the i10-index of Paschalis Karakasis?
ScholarIQi10-index
Paschalis Karakasis has an i10-index of 55 in OpenAlex.
What is the ORCID of Paschalis Karakasis?
ScholarIQorcid
The ORCID for Paschalis Karakasis is on the source record.
What is the OpenAlex record for Paschalis Karakasis?
ScholarIQopenalex
The OpenAlex for Paschalis Karakasis is on the source record.
What are the most-cited papers on Paschalis Karakasis?
ScholarIQmost cited works
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis
Paschalis Karakasis, Dimitrios Patoulias, Nikolaos Fragakis, Christos S. Mantzoros
Prognostic value of stress hyperglycemia ratio in patients with acute myocardial infarction: A systematic review with Bayesian and frequentist meta-analysis
Paschalis Karakasis, Nikolaos Stalikas, Dimitrios Patoulias, Konstantinos Pamporis, Efstratios Karagiannidis, Μarios Sagris, Panagiotis Stachteas, Konstantinos I. Bougioukas, Vasileios Anastasiou, Stylianos Daios, Fani Apostolidou‐Kiouti, George Giannakoulas, Vassilios Vassilikos, Nikolaos Fragakis, Γεώργιος Γιαννόπουλος
Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets
Paschalis Karakasis, Panagiotis Theofilis, Panayotis K. Vlachakis, Panagiotis Korantzopoulos, Dimitrios Patoulias, Antonios P. Antoniadis, Nikolaos Fragakis
Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials
Paschalis Karakasis, Dimitrios Patoulias, Konstantinos Pamporis, Panagiotis Stachteas, Konstantinos I. Bougioukas, Aleksandra Klisić, Nikolaos Fragakis, Manfredi Rizzo
Effect of tirzepatide on albuminuria levels and renal function in patients with type 2 diabetes mellitus: A systematic review and multilevel meta‐analysis
Paschalis Karakasis, Dimitrios Patoulias, Nikolaos Fragakis, Aleksandra Klisić, Manfredi Rizzo